Statins are medications that inhibit the 3-hydroxy-3-methylglutaryl-CoA reductase enzyme, thus inhibiting cholesterol biosynthesis. Statins reduce cardiovascular risk and morbidity in patients with coronaropathia, however, without forgetting their side effect in muscle toxicity. Clinically, patients with myopathy caused by statins are divided into four main groups: those with rhabdomyolysis, myalgia / hyper CPK, toxic myopathy limited by statins and myositis (necrotizing myopathy mediated by immune complexes with anti-HMGCR antibodies, IMNM)
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. HMGCoA reduc...
Eleni Tiniakou Johns Hopkins University School of Medicine, Department of Medicine, Division of Rheu...
Objective: To review the epidemiology, clinical features, proposed mechanisms, risk factors, and man...
Statins are medications that inhibit the 3-hydroxy-3-methylglutaryl-CoA reductase enzyme, thus inhib...
<p>Statins are lipid-lowering drugs with proven efficacy that reduce cardiovascular risk and are wel...
Statins are the most frequently used drugs for lowering the low density lipoprotein (LDL)-cholestero...
Statins are at the forefront of treatments for hyperlipidemia, coronary artery disease and stroke. P...
Statins are considered to be safe, well tolerated and the most efficient drugs for the treatment of ...
Statins are commonly used lipid lowering agents which play a pivotal role in reducing cardiovascular...
Hyperlipidemia is a major risk factor for cardiovascular morbidity and mortality. Statins are the fi...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. HMGCoA reduc...
Eleni Tiniakou Johns Hopkins University School of Medicine, Department of Medicine, Division of Rheu...
Objective: To review the epidemiology, clinical features, proposed mechanisms, risk factors, and man...
Statins are medications that inhibit the 3-hydroxy-3-methylglutaryl-CoA reductase enzyme, thus inhib...
<p>Statins are lipid-lowering drugs with proven efficacy that reduce cardiovascular risk and are wel...
Statins are the most frequently used drugs for lowering the low density lipoprotein (LDL)-cholestero...
Statins are at the forefront of treatments for hyperlipidemia, coronary artery disease and stroke. P...
Statins are considered to be safe, well tolerated and the most efficient drugs for the treatment of ...
Statins are commonly used lipid lowering agents which play a pivotal role in reducing cardiovascular...
Hyperlipidemia is a major risk factor for cardiovascular morbidity and mortality. Statins are the fi...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. HMGCoA reduc...
Eleni Tiniakou Johns Hopkins University School of Medicine, Department of Medicine, Division of Rheu...
Objective: To review the epidemiology, clinical features, proposed mechanisms, risk factors, and man...